Escherichia coli O80 hybrid pathotype strains producing Shiga toxin and ESBL: molecular characterization and potential therapeutic options

Paediatric haemolytic uraemic syndrome related to Shiga toxin-producing Escherichia coli, an overview of 10 years of surveillance in France, 2007 to 2016

(2019) Mathias Bruyand et al.   Eurosurveillance

Genetic characterization of Shiga toxin producing Escherichia coli belonging to the emerging hybrid pathotype O80:H2 isolated from humans 2010–2017 in Switzerland

(2018) Magdalena Nüesch-Inderbinen et al.   INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY

Longitudinal study of Escherichia coli plasmid resistance to extended-spectrum cephalosporins in free-range broilers

(2018) Sandrine Baron et al.   VETERINARY MICROBIOLOGY

Characteristics of Shiga toxin producing- and enteropathogenic Escherichia coli of the emerging serotype O80:H2 isolated from humans and diarrhoeic calves in Belgium

(2018) K. De Rauw et al.   CLINICAL MICROBIOLOGY AND INFECTION

Unusual severe case of hemolytic uremic syndrome due to Shiga toxin 2d-producing E. coli O80:H2

(2017) Kioa L. Wijnsma et al.   PEDIATRIC NEPHROLOGY

Unicycler: Resolving bacterial genome assemblies from short and long sequencing reads

(2017) Ryan R. Wick et al.   PLoS Computational Biology

Characteristics of Shigatoxin-Producing Escherichia coli Strains Isolated during 2010–2014 from Human Infections in Switzerland

(2017) Lisa Fierz et al.   Frontiers in Microbiology

Nucleotide sequences of 16 transmissible plasmids identified in nine multidrug-resistant Escherichia coli isolates expressing an ESBL phenotype isolated from food-producing animals and healthy humans

(2014) Juan Wang et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a microbiological study

(2011) Martina Bielaszewska et al.   LANCET INFECTIOUS DISEASES

Different Classes of Antibiotics Differentially Influence Shiga Toxin Production

(2010) C. M. McGannon et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY